Thalidomide Inhibits Angiogenesis in Embryoid Bodies by the Generation of Hydroxyl Radicals
Open Access
- 1 January 2000
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 156 (1), 151-158
- https://doi.org/10.1016/s0002-9440(10)64714-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the ?optical probe technique?Cytometry, 1998
- Oxidative damage in chemical teratogenesisMutation Research, 1997
- MECHANISMS OF ENDOTHELIAL CELL INJURY IN ACUTE INFLAMMATIONShock, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicityTeratology, 1992
- Hydrogen Peroxide Formation by Cells Treated with a Tumor PromoterFree Radical Research Communications, 1991
- Proposed mechanisms of action in thalidomide embryopathyTeratology, 1988
- Non-confirmation of thalidomide induced teratogenesis in rats and miceTeratology, 1977
- THALIDOMIDE AND CONGENITAL ABNORMALITIESThe Lancet, 1962
- THALIDOMIDE AND CONGENITAL ABNORMALITIESThe Lancet, 1961